• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

GAP NARROWING BETWEEN FACIAL FILLERS

The FDA will review both Medicis Pharmaceutical Corp.'s Restylane and Inamed Corp's Hylaform on November 21.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!
Related Videos
Related Content
Q&A: Bringing Dermatologist Expertise to Everyday Sun Care with SunSolve MD and Revieve
August 15th 2025

Q&A: Bringing Dermatologist Expertise to Everyday Sun Care with SunSolve MD and Revieve

The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
August 15th 2025

The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis

Are Schools Failing Children with Chronic Health Conditions?
August 15th 2025

Are Schools Failing Children with Chronic Health Conditions?

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
August 15th 2025

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

The Latest Trends in Laser and Energy-Based Dermatology
August 15th 2025

The Latest Trends in Laser and Energy-Based Dermatology

Sculptra and Restylane Deliver 9-Month Skin, Confidence Boost Post-Medication Weight Loss
August 15th 2025

Sculptra and Restylane Deliver 9-Month Skin, Confidence Boost Post-Medication Weight Loss

© 2025 MJH Life Sciences

All rights reserved.